304
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon

, &

References

  • Abdul-Quader, A. S., Feelemyer, J., Modi, S., Stein, E. S., Briceno, A., Semaan, S., … Des Jarlais, D. C. (2013). Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: A systematic review. AIDS and Behavior, 17(9), 2878–2892. doi:10.1007/s10461-013-0593-y
  • Abu-Raddad, L. J., Hilmi, N., Mumtaz, G., Benkirane, M., Akala, F. A., Riedner, G., … Wilson, D. (2010). Epidemiology of HIV infection in the Middle East and North Africa. AIDS, 24(Suppl 2), S5–23. doi:10.1097/01.aids.0000386729.56683.33
  • Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., … Hutchinson, S. J. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. International Journal of Epidemiology, 43(1), 235–248. doi:10.1093/ije/dyt243
  • Bastos, F. I., & Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science & Medicine, 51(12), 1771–1782.
  • Beletsky, L., Heller, D., Jenness, S. M., Neaigus, A., Gelpi-Acosta, C., & Hagan, H. (2014). Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: A community-level perspective. International Journal of Drug Policy, 25(1), 105–111. doi:10.1016/j.drugpo.2013.06.005
  • Booth, R. E., Dvoryak, S., Sung-Joon, M., Brewster, J. T., Wendt, W. W., Corsi, K. F., … Strathdee, S. A. (2013). Law enforcement practices associated with HIV infection among injection drug users in Odessa, Ukraine. AIDS and Behavior, 17(8), 2604–2614. doi:10.1007/s10461-013-0500-6
  • Bozicevic, I., Riedner, G., & Calleja, J. M. (2013). HIV surveillance in MENA: Recent developments and results. Sexually Transmitted Infections, 89(Suppl 3), iii11–16. doi:10.1136/sextrans-2012-050849
  • Coffin, P. O., Linas, B. P., Factor, S. H., & Vlahov, D. (2000). New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. Journal of Urban Health, 77(4), 781–793. doi:10.1007/BF02344038
  • Cooper, H. L. F., Des Jarlais, D. C., Ross, Z., Tempalski, B., Bossak, B., & Friedman, S. R. (2011). Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes. American Journal of Public Health, 101(6), 1118–1125. doi:10.2105/AJPH.2009.184580
  • Davidson, P. J., Lozada, R., Rosen, P. C., Macias, A., Gallardo, M., & Pollini, R. A. (2012). Negotiating access: Social barriers to purchasing syringes at pharmacies in Tijuana, Mexico. International Journal of Drug Policy, 23(4), 286–294. doi:10.1016/j.drugpo.2012.05.001
  • Deibert, R. J., Goldbaum, G., Parker, T. R., Hagan, H., Marks, R., Hanrahan, M., & Thiede, H. (2006). Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: Structural and individual-level changes, 1996 versus 2003. American Journal of Public Health, 96(8), 1347–1353. doi:10.2105/AJPH.2003.032698
  • Des Jarlais, D. C., Feelemyer, J. P., Modi, S. N., Abdul-Quader, A., & Hagan, H. (2013). High coverage needle/syringe programs for people who inject drugs in low and middle income countries: A systematic review. BMC Public Health, 13, 53. doi:10.1186/1471-2458-13-53
  • Emmanuel, F., Salim, M., Akhtar, N., Arshad, S., & Reza, T. E. (2013). Second-generation surveillance for HIV/AIDS in Pakistan: Results from the 4th round of Integrated Behavior and Biological Survey 2011-2012. Sexually Transmitted Infections, 89(Suppl 3), iii23–28. doi:10.1136/sextrans-2013-051161
  • Family Health International and Ministry of Health Egypt. (2010). HIV/AIDS Biological & Behavioral Surveillance Survey: Summary report. Retrieved from https://www.fhi360.org/sites/default/files/media/documents/EgyptBioBSSsummaryreport2006.pdf
  • Fedorova, E. V., Skochilov, R. V., Heimer, R., Case, P., Beletsky, L., Grau, L. E., … Shaboltas, A. V. (2013). Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: Syringe purchase test study. BMC Public Health, 13, 183. doi:10.1186/1471-2458-13-183
  • Glaser, B. G., & Strauss, A. L. (1967). The discovery of grounded theory: Strategies for qualitative research. London, UK: Aldine.
  • Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59–82.
  • Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91(1), 42–46.
  • Khajehkazemi, R., Osooli, M., Sajadi, L., Karamouzian, M., Sedaghat, A., Fahimfar, N., … Haghdoost, A. A. (2013). HIV prevalence and risk behaviours among people who inject drugs in Iran: The 2010 National Surveillance Survey. Sexually Transmitted Infections, 89(Suppl 3), iii29–32. doi:10.1136/sextrans-2013-051204
  • Lewis, B. A., Koester, S. K., & Bush, T. W. (2002). Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. Journal of the American Pharmacists Association, 42(6 Suppl 2), S46–51.
  • Lutnick, A., Cooper, E., Dodson, C., Bluthenthal, R., & Kral, A. H. (2013). Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010. Journal of Urban Health, 90(2), 276–283. doi:10.1007/s11524-012-9713-7
  • MacArthur, G. J., van Velzen, E., Palmateer, N., Kimber, J., Pharris, A., Hope, V., … Hutchinson, S. J. (2014). Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness. International Journal of Drug Policy, 25(1), 34–52. doi:10.1016/j.drugpo.2013.07.001
  • Mahfoud, Z., Afifi, R., Ramia, S., El Khoury, D., Kassak, K., El Barbir, F., … DeJong, J. (2010). HIV/AIDS among female sex workers, injecting drug users and men who have sex with men in Lebanon: Results of the first biobehavioral surveys. AIDS, 24(Suppl 2), S45–54. doi:10.1097/01.aids.0000386733.02425.98
  • Mahfoud, Z., Kassak, K., Kreidieh, K., Shamra, S., & Ramia, S. (2010). Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon. Virology Journal, 7, 96. doi:10.1186/1743-422X-7-96
  • Marotta, P. L., & McCullagh, C. A. (2016). A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011. International Journal of Drug Policy, 32, 3–10. doi:10.1016/j.drugpo.2016.02.007
  • Mathers, B. M., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R. P., … Strathdee, S. A. (2010). HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet, 375(9719), 1014–1028. doi:10.1016/S0140-6736(10)60232-2
  • McNeil, R., & Small, W. (2014). ‘Safer environment interventions’: A qualitative synthesis of the experiences and perceptions of people who inject drugs. Social Science & Medicine, 106, 151–158. doi:10.1016/j.socscimed.2014.01.051
  • Mirzoyan, L., Berendes, S., Jeffery, C., Thomson, J., Ben Othman, H., Danon, L., … Valadez, J. J. (2013). New evidence on the HIV epidemic in Libya: Why countries must implement prevention programs among people who inject drugs. Journal of Acquired Immune Deficiency Syndromes, 62(5), 577–583. doi:10.1097/QAI.0b013e318284714a
  • Mumtaz, G. R., Riedner, G., & Abu-Raddad, L. J. (2014). The emerging face of the HIV epidemic in the Middle East and North Africa. Current Opinion in HIV AIDS, 9(2), 183–191. doi:10.1097/COH.0000000000000038
  • Mumtaz, G. R., Weiss, H. A., Thomas, S. L., Riome, S., Setayesh, H., Riedner, G., … Abu-Raddad, L. J. (2014). HIV among people who inject drugs in the Middle East and North Africa: Systematic review and data synthesis. PLoS Medicine, 11(6), e1001663. doi:10.1371/journal.pmed.1001663
  • Nasir, A., Todd, C. S., Stanekzai, M. R., Bautista, C. T., Botros, B. A., Scott, P. T., … Tjaden, J. (2011). Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. International Journal of Drug Policy, 22(2), 145–152. doi:10.1016/j.drugpo.2010.10.006
  • National AIDS Control Program, Ministry of Health, Pakistan. (2007). HIV second generation surveillance in Pakistan: National report, round II. Retrieved from http://www.nacp.gov.pk/repository/whatwedo/surveillance/HIV%20Second%20Generation%20Surveillance%20in%20Pakistan%20-%20Round%202%20Report%202006-07.pdf
  • Nazari, S. S., Noroozi, M., Soori, H., Noroozi, A., Mehrabi, Y., Hajebi, A., … Mirzazadeh, A. (2016). The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. International Journal of Drug Policy, 27, 127–131. doi:10.1016/j.drugpo.2015.10.011
  • Obermeyer, C. M. (2006). HIV in the Middle East. BMJ, 333(7573), 851–854. doi:10.1136/bmj.38994.400370.7C
  • O'Reilly, M. (2013). ‘Unsatisfactory saturation’: A critical exploration of the notion of saturated sample sizes in qualitative research. Qualitative Research, 13, 190–197.
  • Palmateer, N., Kimber, J., Hickman, M., Hutchinson, S., Rhodes, T., & Goldberg, D. (2010). Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews. Addiction, 105(5), 844–859. doi:10.1111/j.1360-0443.2009.02888.x
  • Pollini, R. A., Lozada, R., Gallardo, M., Rosen, P., Vera, A., Macias, A., … Strathdee, S. A. (2010). Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: A mixed methods study. AIDS and Behavior, 14(3), 679–687. doi:10.1007/s10461-010-9674-3
  • Razani, N., Mohraz, M., Kheirandish, P., Malekinejad, M., Malekafzali, H., Mokri, A., … Rutherford, G. (2007). HIV risk behavior among injection drug users in Tehran, Iran. Addiction, 102(9), 1472–1482. doi:10.1111/j.1360-0443.2007.01914.x
  • Ruiseñor-Escudero, H., Wirtz, A. L., Berry, M., Mfochive-Njindan, I., Paikan, F., Yousufi, H. A., … Vu, A. (2014). Risky behavior and correlates of HIV and hepatitis C virus infection among people who inject drugs in three cities in Afghanistan. Drug Alcohol Depend, 143, 127–133. doi:10.1016/j.drugalcdep.2014.07.022
  • SIDC. (2015). Needle & syringe programs: Strategies, outreach and ethics ( Unpublished internal document).
  • Stopka, T. J., Garfein, R. S., Ross, A., & Truax, S. R. (2007). Increasing syringe access and HIV prevention in California: Findings from a survey of local health jurisdiction key personnel. Journal of Urban Health, 84(1), 116–125. doi:10.1007/s11524-006-9122-x
  • Stopka, T. J., Geraghty, E. M., Azari, R., Gold, E. B., & DeRiemer, K. Is crime associated with over-the-counter pharmacy syringe sales? Findings from Los Angeles, California. International Journal of Drug Policy, 25(2), 244–250. doi:10.1016/j.drugpo.2013.12.015
  • Taussig, J. A., Weinstein, B., Burris, S., & Jones, T. S. (2000). Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS, 14(Suppl 1), S47–51.
  • Tavitian-Exley, I., Vickerman, P., Bastos, F. I., & Boily, M. C. (2015). Influence of different drugs on HIV risk in people who inject: Systematic review and meta-analysis. Addiction, 110(4), 572–584. doi:10.1111/add.12846
  • Todd, C. S., Abed, A. M., Strathdee, S. A., Scott, P. T., Botros, B. A., Safi, N., & Earhart, K. C. (2007). HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerging Infectious Diseases, 13(9), 1327–1331. doi:10.3201/eid1309.070036
  • Vazirian, M., Nassirimanesh, B., Zamani, S., Ono-Kihara, M., Kihara, M., Ravari, S. M., & Gouya, M. M. (2005). Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduction Journal, 2, 19. doi:10.1186/1477-7517-2-19
  • Wagner, K. D., Davidson, P. J., Pollini, R. A., Strathdee, S. A., Washburn, R., & Palinkas, L. A. (2012). Reconciling incongruous qualitative and quantitative findings in mixed methods research: Exemplars from research with drug using populations. International Journal of Drug Policy, 23(1), 54–61. doi:10.1016/j.drugpo.2011.05.009
  • Wodak, A. (2006). Lessons from the first international review of the evidence for needle syringe programs: The band still plays on. Substance Use & Misuse, 41(6–7), 837–839. doi:10.1080/10826080600669587
  • Wodak, A., & Cooney, A. (2006). Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use & Misuse, 41(6–7), 777–813. doi:10.1080/10826080600669579
  • Zamani, S., Vazirian, M., Nassirimanesh, B., Razzaghi, E. M., Ono-Kihara, M., Mortazavi Ravari, S., … Kihara, M. (2010). Needle and syringe sharing practices among injecting drug users in Tehran: A comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS and Behavior, 14(4), 885–890. doi:10.1007/s10461-008-9404-2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.